Drug probes resumed by UK CMA following Covid-19 delay
MLex Summary: The UK Competition and Markets Authority has resumed two antitrust probes into the supply of drugs. The first is the CMA's investigation into AMCo (now Advanz Pharma), Morningside Healthcare, Morningside Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article